Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options: (Tables)

v3.21.2
Stock-Based Compensation, Restricted Stock and Stock Options: (Tables)
3 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock based compensation expenses
    Three months ended
June 30,
 
    2021     2020  
    (Unaudited)     (Unaudited)  
Research and development expenses   $ 32     $ 1,152  
Selling, general and administrative expenses     2,551       7,209  
Total stock-based compensation   $ 2,583     $ 8,361  

 

Schedule of restricted stock awards
    Number of
Shares
    Weighted
Average
Grant-Date
Fair Value
 
Unvested at March 31, 2021     777,778     $ 5.12  
Vested     (66,666 )   $ 5.12  
Unvested at June 30, 2021 (unaudited)     711,112     $ 5.12  

 

Schedule of stock options granted
    Three Months Ended  
    2021     2020  
Dividend yield     0 %     0 %
Expected price volatility     50 %     50 %
Risk free interest rate     0.35% - 0.90 %     0.16% - 0.44 %
Expected term     3-5 years       5-6 years  

 

Schedule of stock options activity
    Shares Underlying Options     Weighted Average Exercise Price     Weighted Average Remaining Contractual
Term (Years)
    Aggregate Intrinsic Value  
Outstanding at March 31, 2021     10,861,940     $ 2.73       8.2     $ 17,524  
Granted     248,147     $ 4.41       6.2      
 
 
Canceled     (571,379 )   $ 3.32      
-
     
 
 
Outstanding at June 30, 2021 (unaudited)     10,538,708     $ 2.74       7.8     $ 16,098  
                                 
Exercisable at June 30, 2021 (unaudited)     10,025,932     $ 2.63       7.8     $ 16,093  

 

Schedule of warrant activity
    Shares Underlying Warrants     Weighted Average Exercise Price     Weighted Average Remaining Contractual
Term (Years)
    Aggregate Intrinsic Value  
Outstanding at March 31, 2021     3,883,083     $ 2.49       4.6     $ 7,763  
Outstanding at June 30, 2021 (unaudited)     3,883,083     $ 2.49       4.3     $ 7,502  
                                 
Exercisable at June 30, 2021 (unaudited)     3,267,698     $ 1.93       4.1     $ 6,320